Edition:
United Kingdom

Seikagaku Corp (4548.T)

4548.T on Tokyo Stock Exchange

1,719JPY
4:47am BST
Change (% chg)

¥31 (+1.84%)
Prev Close
¥1,688
Open
¥1,703
Day's High
¥1,720
Day's Low
¥1,685
Volume
50,600
Avg. Vol
102,462
52-wk High
¥2,236
52-wk Low
¥1,383

Chart for

About

SEIKAGAKU CORPORATION is principally engaged in the research, development, purchase, manufacture and sale of pharmaceutical products and limulus amebocyte lysate (LAL). The Company operates in two business segments. The Pharmaceutical business segment provides hyaluronan-based medicines for joint function improvement, ophthalmic... (more)
No analyst recommendations are available for .

Overall

Beta: 0.44
Market Cap(Mil.): ¥96,640.77
Shares Outstanding(Mil.): 56.81
Dividend: 13.00
Yield (%): 1.53

Financials

  4548.T Industry Sector
P/E (TTM): 22.91 30.43 32.65
EPS (TTM): 74.26 -- --
ROI: 5.62 13.04 12.72
ROE: 5.83 14.97 14.84

BRIEF-Seikagaku announces new drug application approval of hernicore® 1.25 units for intradiscal injection in Japan

* Says it announced that the Japanese Ministry of Health, Labour and Welfare has approved the new drug application of HERNICORE® 1.25 units for intradiscal injection in Japan, indicated for the treatment of lumbar disc herniation

23 Mar 2018

Earnings vs. Estimates